Acute Condition

From the archive: Dry ice and millions of secret chickens

When the government absolutely has to get involved in production

Dec 23, 2025 • Olivia Webb Kosloff

4

1

Will expensive cell and gene therapies force a different insurance structure?

Or we’ll all just suffer instead

Dec 16, 2025 • Olivia Webb Kosloff

11

6

Company size is warping the healthcare market

Healthcare startups are stuck playing an Amazon HQ2 game

Dec 5, 2025 • Olivia Webb Kosloff

10

2

November 2025

Botulism, recalls, and the open weaknesses in America’s formula supply

The structural flaws that make our formula manufacturing vulnerable

Nov 20, 2025 • Olivia Webb Kosloff

5

The end of the independent doctor and the future of healthcare reform

The doctors become the working class

Nov 12, 2025 • Olivia Webb Kosloff

12

October 2025

The war of pricing bots

Accelerationism...but for downcoding

Oct 29, 2025 • Olivia Webb Kosloff

8

1

Provider consolidation: an interview with Health Tech Nerds's Martin Cech

I talked to Martin, HTN's Lead Policy Research Analyst, about provider independence

Oct 22, 2025 • Olivia Webb Kosloff

8

1

MultiPlan: still secretive, still there

Now with tools that make things even harder on providers and patients

Oct 17, 2025 • Olivia Webb Kosloff

9

Private equity in healthcare

My tl;dr: it's bad

Oct 8, 2025 • Olivia Webb Kosloff

14

1

2

September 2025

Generic drugs by another name?

A lack of enforcement is backing us into a new pathway for drug manufacturing

Sep 25, 2025 • Olivia Webb Kosloff

6

1

Friday special edition: Anti-Monopoly Summit

This post is a little late, but for good reason — I spent the first part of this week in DC attending the 2025 Anti-Monopoly Summit.

Sep 19, 2025 • Olivia Webb Kosloff

7

1

GLP-1s are propping up virtual care startups

What happens when the compounding stops?

Sep 11, 2025 • Olivia Webb Kosloff

12

2

1